Successful treatment of molluscum contagiosum with topical imiquimod in a severely immunocompromised HIV-positive patient

被引:31
作者
Strauss, RM [1 ]
Doyle, EL [1 ]
Mohsen, AH [1 ]
Green, ST [1 ]
机构
[1] Royal Hallamshire Hosp, Dept Dermatol, Sheffield S10 2RA, S Yorkshire, England
关键词
molluscum contagiosum; topical imiquimod; HIV; immunocompromised;
D O I
10.1258/0956462011922832
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Molluscum contagiosum is a common viral infection in the immunocompromised HIV-positive patient where it is often severe and affecting the face and neck. It is frequently resistant to conventional, locally destructive therapies. Anecdotal evidence suggests that the immunomodulatory drug imiquimod might be a valid therapeutic option in this group of patients. We report the case of a severely immunocompromised HIV-positive patient with resistant facial molluscum contagiosum lesions that responded to topical imiquimod. The response to therapy and the possible implications for pathogenesis are discussed.
引用
收藏
页码:264 / 266
页数:3
相关论文
共 22 条
[1]   REDUCED LANGERHANS CELL IA-ANTIGEN AND ATPASE ACTIVITY IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
BELSITO, DV ;
SANCHEZ, MR ;
BAER, RL ;
VALENTINE, F ;
THORBECKE, GJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (20) :1279-1282
[2]  
Brown CW, 2000, CUTIS, V65, P363
[3]   Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus 1 disease [J].
Buckley, R ;
Smith, K .
ARCHIVES OF DERMATOLOGY, 1999, 135 (10) :1167-1169
[4]  
Calista D, 1999, EUR J DERMATOL, V9, P211
[5]   PREVALENCE AND CLINICAL SPECTRUM OF SKIN-DISEASE IN PATIENTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS [J].
COLDIRON, BM ;
BERGSTRESSER, PR .
ARCHIVES OF DERMATOLOGY, 1989, 125 (03) :357-361
[6]  
CRUZ PD, 1991, DERMATOL CLIN, V9, P633
[7]   INTERFERON THERAPY FOR CONDYLOMATA ACUMINATA [J].
ERON, LJ ;
JUDSON, F ;
TUCKER, S ;
PRAWER, S ;
MILLS, J ;
MURPHY, K ;
HICKEY, M ;
ROGERS, M ;
FLANNIGAN, S ;
HIEN, N ;
KATZ, HI ;
GOLDMAN, S ;
GOTTLIEB, A ;
ADAMS, K ;
BURTON, P ;
TANNER, D ;
TAYLOR, E ;
PEETS, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (17) :1059-1064
[8]   A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients [J].
Gilson, RJC ;
Shupack, JL ;
Friedman-Kien, AE ;
Conant, MA ;
Weber, JN ;
Nayagam, AT ;
Swann, RV ;
Pietig, DC ;
Smith, MH ;
Owens, ML .
AIDS, 1999, 13 (17) :2397-2404
[9]   Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification [J].
Goldstein, D ;
Hertzog, P ;
Tomkinson, E ;
Couldwell, D ;
McCarville, S ;
Parrish, S ;
Cunningham, P ;
Newell, M ;
Owens, M ;
Cooper, DA .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (03) :858-861
[10]   PREVALENCE OF CUTANEOUS DISEASE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) OR AIDS-RELATED COMPLEX [J].
GOODMAN, DS ;
TEPLITZ, ED ;
WISHNER, A ;
KLEIN, RS ;
BURK, PG ;
HERSHENBAUM, E .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 17 (02) :210-220